T. Rowe Price Investment Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$324K Buy
1,866
+1,095
+142% +$224K ﹤0.01% 638
2025
Q4
$198K Sell
771
-60,659
-99% -$15.9M ﹤0.01% 656
2025
Q3
$16M Buy
61,430
+48,762
+385% +$12.8M 0.01% 527
2025
Q2
$3.1M Sell
12,668
-154,902
-92% -$38.6M ﹤0.01% 590
2025
Q1
$44.3M Sell
167,570
-1,438,201
-90% -$389M 0.03% 419
2024
Q4
$407M Buy
1,605,771
+160,952
+11% +$43.2M 0.25% 108
2024
Q3
$458M Buy
1,444,819
+518,057
+56% +$184M 0.28% 98
2024
Q2
$346M Buy
926,762
+269,824
+41% +$91.1M 0.22% 110
2024
Q1
$228M Buy
656,938
+486,503
+285% +$184M 0.14% 175
2023
Q4
$78M Sell
170,435
-727,649
-81% -$359M 0.05% 319
2023
Q3
$437M Buy
898,084
+851,860
+1,843% +$400M 0.31% 100
2023
Q2
$20.7M Buy
+46,224
New +$23.3M 0.01% 471

Other funds holding HUM

T. Rowe Price Investment Management's HUM Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Humana (HUM) stake by 142% in Q1 2026, buying an estimated $224K and bringing the position to 1,866 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #638.

T. Rowe Price Investment Management first reported a position in HUM in Q2 2023 and has held it in 12 quarters since. The position peaked at $458M in Q3 2024. 782 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • T. Rowe Price Investment Management held 1,866 shares of Humana worth $324K as of Q1 2026.
  • T. Rowe Price Investment Management bought 1,095 Humana shares in Q1 2026, an estimated $224K.
  • Humana made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #638 holding.
  • T. Rowe Price Investment Management first reported a position in Humana in Q2 2023 and has held it in 12 quarters since.
  • T. Rowe Price Investment Management's Humana position peaked at $458M in Q3 2024.
  • 782 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.